| Quarter | Score |
|---|---|
| 2022-Q1 | 49.3 |
| 2022-Q3 | 66.2 |
| 2022-Q4 | 50.4 |
| 2023-Q1 | 50.2 |
| 2023-Q2 | 63.9 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 60.2 |
| 2024-Q2 | 66.2 |
| 2024-Q3 | 57.4 |
| 2024-Q4 | 57.5 |
| 2025-Q1 | 58.5 |
| 2025-Q2 | 61.8 |
| 2025-Q3 | 98.5 |
| 2025-Q4 | 85.9 |
| 2026-Q1 | 85.9 |
| 2026-Q2 | 86.0 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +47.1% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold RIG. Avg conviction: 15.3%. Net holding. First tracked at $3.69 (current +47.1% vs tracked).
Pabrai Investment Funds has 30.5% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Pabrai Investment Funds | 30.5% | Add |
| Citadel Advisors | 0.0% | Reduce |